Macerich's moves to improve its portfolio quality were necessary
Analysts are decreasing fair value estimate to $29.50 per share from $32.50 per share after incorporating fourth-quarter results and adjusting our assumptions for the impact of the coronavirus.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。